Sara Miranda, PharmD

Epidemiologist
EPI-PHARE (ANSM/CNAM), France

Sara Miranda is a senior pharmacoepidemiologist at EPI-PHARE, graduated from the Faculty of Pharmacy of Porto (PharmD), and specialized in epidemiology and statistics in France (MSc). During the last 15 years, Sara has contributed to pharmacoepidemiological studies both in the private and public sectors, and her main area of research is the use and safety of medications during pregnancy.

Disclosure information not submitted.

Presentation(s):

• Association between macrolide exposure in early pregnancy and major congenital malformations: a large French population-based study during 2010-20 period

  Monday, August 26, 2024
  2:00 PM – 2:15 PM CEST

• Adverse pregnancy outcomes associated with in utero exposure to multiple sclerosis disease-modifying therapies in France: a nationwide cohort study

  Tuesday, August 27, 2024
  1:30 PM – 1:45 PM CEST

• Prescription medication use during pregnancy in France between 2010 and 2022: a nationwide study

  Wednesday, August 28, 2024
  9:45 AM – 10:00 AM CEST